Latest debt-to-equity ratio
Enliven Therapeutics Debt-to-equity ratio
Direct answer
Enliven Therapeutics's debt-to-equity ratio is 0.17%.
The verified market snapshot reports 0.17%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.17%
Explore related company data
View Enliven Therapeutics's market capitalizationView Enliven Therapeutics's price-to-book ratioView Enliven Therapeutics's return on equityView Enliven Therapeutics's dividend yieldView Enliven Therapeutics's 52-week price rangeView Enliven Therapeutics's profit marginView all Enliven Therapeutics key metricsReturn to Enliven Therapeutics profile